# Micafungin

## Mycamine inj 50mg

| TAH Drug Code      | [IMYC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMYC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Candidemia， acute disseminated candidiasis， and Candida peritonitis and abscesses， Esophageal candidiasis， Prophylaxis of Candida infection in hematopoietic stem cell transplantation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Adult: Candida esophagitis: 150 mg IV Q24H; candidemia: 100 mg IV Q24H; prophylaxis， post transplant: 50 mg IV Q24H. Children > 4 months: Esophageal candidiasis: (weight< 30 kg) 3 mg/kg Q24H or (weight > 30 kg) 2.5 mg/kg Q24H (maximum 150 mg); candidiasis: 2 mg/kg Q24H (maximum 100 mg); prophylaxis in HSCT recipients: 1 mg/kg Q24H (maximum 50 mg).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Hypersensitivity to micafungin， other echinocandins， or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | >10%: Cardiovascular: Tachycardia (3% to 26%)， localized phlebitis (with peripheral administration; 5% to 19%) Central nervous system: Headache (2% to 44%)， insomnia (4% to 37%)， anxiety (?23%)， dizziness (13%) Dermatologic: Pruritus (pediatric patients ages 3 days through 16 years: ?33%; adults 6%)， skin rash (2% to 30%)， urticaria (pediatric patients ages 3 days through 16 years: ?19%; adults <5%) Endocrine & metabolic: Hypokalemia (14% to 18%)， hypomagnesemia (6% to 13%) Gastrointestinal: Diarrhea (7% to 77%)， nausea (7% to 71%)， vomiting (7% to 66%)， abdominal pain (2% to 35%)， abdominal distension (pediatric patients ages 3 days through 16 years: 2% to 19%)， mucositis (14%)， constipation (11%) Genitourinary: Decreased urine output (pediatric patients ages 3 days through 16 years: ?23%)， hematuria (pediatric patients ages 3 days through 16 years: ?23%) Hematologic & oncologic: Neutropenia (5% to 75%)， thrombocytopenia (4% to 75%)， anemia (pediatric patients ages 3 days through 16 years: 13% to 51%; adults 3% to 10%)， febrile neutropenia (?16%) Hepatic: Increased serum ALT (pediatric patients ages 3 days through 16 years: ?16%; adults 5%)， abnormal hepatic function tests (pediatric patients ages 3 days through 16 years: <15%; adults 4%)， hyperbilirubinemia (pediatric patients ages 3 days through 16 years: <15%; adults <1%) Renal: Renal failure (pediatric patients ages 3 days through 16 years: <15%) Miscellaneous: Fever (pediatric patients ages 3 days through 16 years: 9% to 61%; adults 7% to 20%)， infusion related reaction (pediatric patients ages 3 days through 16 years: ?16%; adults <5%) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/micafungin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## Myfungin inj 50mg

| TAH Drug Code      | [IMYF](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMYF)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Candidemia and esophageal candidiasis treatment in adults and children over 4 months， and Candida infection prevention in stem cell transplant recipients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Adult: Candidal endocarditis: 150 mg IV daily， followed by step-down therapy with fluconazole 400 to 800 mg (6 to 12 mg/kg) daily. Candidemia: 100 mg once daily as IV infusion over 1 hour; mean duration of therapy in clinical studies was 15 days. Candidiasis of the esophagus: 150 mg/day IV infusion over 1 hour; for 14 to 21 days. Invasive candidiasis， Hematopoietic Stem Cell Transplantation; Prophylaxis: 50 mg/day IV infusion over 1 hour ; mean duration for prophylaxis (clinical studies)， 19 days (range， 6 to 51 days). Pediatric:[仿單僅收錄4個月以上兒童] Candidemia， Invasive candidiasis: (Younger than 4 months， without meningoencephalitis and/or ocular dissemination) 4 mg/kg once daily as IV infusion over 1 hour. (4 months or older) 2 mg/kg once daily as IV infusion over 1 hour; MAX 100 mg/day. Candidiasis of the esophagus: (30 kg or less) 3 mg/kg IV infusion over 1 hour once daily. (greater than 30 kg) 2.5 mg/kg IV infusion over 1 hour once daily; MAX 150 mg/day. Invasive candidiasis， Hematopoietic Stem Cell Transplantation; Prophylaxis: 1 mg/kg IV infused over 1 hour once daily; MAX 50 mg/day. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypersensitivity to micafungin， other echinocandins， or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Acidosis (Pediatric， 20%)， Hypokalemia (Pediatric， 25%)， Diarrhea (Treatment， 7-<15%; prophylaxis， 51-77%)， Nausea (Treatment， 7-10%; prophylaxis， 70-71%)， Vomiting (Treatment， 7-18%; prophylaxis， 65-66%)， Thrombocytopenia (Treatment， 9-25%; prophylaxis， 72-75%)， Headache (Treatment， 9%; prophylaxis， 44%)， Anemia (Treatment， 15-18%; prophylaxis， 51%).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/micafungin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

